Access to anti-retroviral drugs, female in Senegal
Senegal: Access to anti-retroviral drugs, female was 98.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Senegal, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Senegal stood at 98.0%. That is the highest value across all 25 years on record.
The figure is up 2.1% on the previous year and up 75.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Senegal peaked at 98.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Senegal 1st out of 141 countries with data for 2024, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Senegal, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 30.0% | +2900.0% |
| 2008 | 35.0% | +16.7% |
| 2009 | 40.0% | +14.3% |
| 2010 | 45.0% | +12.5% |
| 2011 | 48.0% | +6.7% |
| 2012 | 44.0% | -8.3% |
| 2013 | 48.0% | +9.1% |
| 2014 | 56.0% | +16.7% |
| 2015 | 59.0% | +5.4% |
| 2016 | 72.0% | +22.0% |
| 2017 | 77.0% | +6.9% |
| 2018 | 87.0% | +13.0% |
| 2019 | 92.0% | +5.7% |
| 2020 | 93.0% | +1.1% |
| 2021 | 94.0% | +1.1% |
| 2022 | 94.0% | +0.0% |
| 2023 | 96.0% | +2.1% |
| 2024 | 98.0% | +2.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.6% | 0.0% | 40.0% | 10 |
| 2010s | 62.8% | 44.0% | 92.0% | 10 |
| 2020s | 95.0% | 93.0% | 98.0% | 5 |
Countries ranked near Senegal
More gender data for Senegal
- Child population (UN estimates and projections) 7,600 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.35 % change on previous year (2030)
- Population 13,563 (2030)
- Working-age population (UN estimates and projections) 13,563 (2030)
- Population (UN estimates and projections), annual growth rate 2.69 % change on previous year (2030)
- Age population, age 00, female, interpolated 263,002 (2025)
- Age population, age 00, male, interpolated 269,605 (2025)
- Age population, age 01, female, interpolated 257,895 (2025)
- Age population, age 01, male, interpolated 263,988 (2025)
- Age population, age 02, female, interpolated 250,294 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Senegal?
- Access to anti-retroviral drugs, female in Senegal was 98.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Senegal?
- The highest recorded value was 98.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Senegal?
- The lowest recorded value was 0.0% in 2000.
- How does Senegal rank for access to anti-retroviral drugs, female?
- Senegal ranks 1st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Senegal?
- Over the last ten years it is up 75.0%. The long-run trend across the full record is volatile.
- Where does this Senegal data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.